Product Information
METHENAMINE HIPP 1 GM TABLET is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $0.3126 per EA under NDC 50742014201. Its NADAC has been published 288 times since Mar 31, 2021.
FDA first approved this application on Nov 27, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 g/1
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742014201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHENAMINE HIPPURATEApproval Type
Generic (ANDA)
FDA Application
ANDA210068FDA Approved
11/27/2020
TE Code
AB
On Market Since
12/18/2020
Price Statistics
The NADAC for METHENAMINE HIPP 1 GM TABLET has been published 288 times since Mar 31, 2021, and over the history we have for it it has declined 74.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3126 per EA |
|---|---|
| All-time high | $1.2147 (Apr 14, 2021) |
| All-time low | $0.3070 (Mar 18, 2026) |
| 52-week high | $0.3673 |
| 52-week low | $0.3070 |
| Median price | $0.4526 |
| Average price | $0.5314 |
| Largest weekly change | +27.1% (Aug 21, 2024) |
| Weeks tracked | 288 |
| Tracking since | Mar 31, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the methenamine hippurate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ingenus Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
methenamine hippurate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHENAMINE HIPP 1 GM TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHENAMINE HIPP 1 GM TABLET, manufactured by Ingenus Pharmaceuticals LLC, is $0.3126 per EA (NDC 50742014201), effective Sep 30, 2026.
How has the price of METHENAMINE HIPP 1 GM TABLET changed over time?
Over the history we have for it, the NADAC for METHENAMINE HIPP 1 GM TABLET has declined 74.3%. It has been tracked across 288 weekly CMS publications since Mar 31, 2021.
What are the highest and lowest recorded NADAC prices for METHENAMINE HIPP 1 GM TABLET?
Since Mar 31, 2021, the NADAC for METHENAMINE HIPP 1 GM TABLET has ranged from a low of $0.3070 (Mar 18, 2026) to a high of $1.2147 (Apr 14, 2021), with a median of $0.4526 per EA.
Are there cheaper alternatives to METHENAMINE HIPP 1 GM TABLET?
No other NADAC-published product currently shares the active ingredient and strength of METHENAMINE HIPP 1 GM TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures METHENAMINE HIPP 1 GM TABLET?
METHENAMINE HIPP 1 GM TABLET (NDC 50742014201) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.